Walker Paul Edward
CIK 0001553150
Director10% Owner
Filings
21
Latest Mar 12, 2026
Issuers covered
10
Showing
21 of 21
Page 1
Track record
8 of 14 open-market trades scored (57% price coverage) - 6 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 8 | 50% | -9.4% | -11.5% | +13.9% | -36.8% |
| 90 days | 7 | 43% | -5.5% | -9.2% | +31.3% | -62.6% |
| 180 days | 6 | 33% | -23.8% | -36.0% | +35.7% | -59.1% |
| 365 days | 6 | 17% | -33.2% | -43.9% | +58.0% | -76.1% |
Issuers
Companies where Walker Paul Edward has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| BHG | Bright Health Group Inc. | 8 | Oct 6, 2025 |
| ALLK | Allakos Inc. | 4 | May 15, 2025 |
| KRRO | Korro Bio, Inc. | 2 | Mar 12, 2026 |
| GNCA | Genocea Biosciences, Inc. | 1 | May 26, 2022 |
| MBX | Mbx Biosciences, Inc. | 1 | Sep 17, 2024 |
| MRKR | Marker Therapeutics, Inc. | 1 | Dec 23, 2024 |
| MIRM | Mirum Pharmaceuticals, Inc. | 1 | Jun 15, 2023 |
| SVRA | Savara Inc | 1 | Jul 19, 2023 |
| SGP | Spyglass Pharma, Inc. | 1 | Feb 11, 2026 |
| TRVI | Trevi Therapeutics, Inc. | 1 | Apr 13, 2022 |
All filings
21 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|